Physician profile
Angelina E Collins
NPI 1720001324
$356,079.75
in general payments reported to CMS, 2019-2025
13 companies · $113K in 2025
The $113K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39K · 2022: $64K · 2023: $55K · 2024: $86K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $183K · Consulting Fee: $38K · Travel and Lodging: $26K · Food and Beverage: $6,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $182,852.50 |
| Consulting Fee | $37,974.00 |
| Travel and Lodging | $26,294.62 |
| Food and Beverage | $6,675.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141,170.87 | 2021-2025 | |
| Janssen Biotech, INC. | $114,841.59 | 2021-2025 | Tremfya, Stelara |
| Janssen Scientific Affairs, LLC | $33,225.83 | 2021-2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $32,940.25 | 2021-2025 | Entyvio |
| Lilly USA, LLC | $24,958.51 | 2022-2025 | Omvoh |
| Eli Lilly and Company | $3,904.56 | 2024 | Omvoh |
| E.R. Squibb & Sons, L.L.C. | $3,689.74 | 2021-2023 | Zeposia |
| Celltrion USA INC. | $955.00 | 2025 | |
| Celgene Corporation | $226.04 | 2022-2024 | Zeposia |
| Inspire Medical Systems, INC. | $84.96 | 2025 | Inspire |
| Atricure, INC. | $48.09 | 2024 | |
| Astellas Pharma US INC | $22.31 | 2022 | |
| Medtronic, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelina Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.